Previous Article | Next Article ![]()
Journal of Virology, October 2001, p. 9596-9600, Vol. 75, No. 20
Institute of Virology, University of Zurich,
Zurich, Switzerland,1 and Institute of
Immunology, Faculty of Veterinary Medicine, University of Leipzig,
Leipzig, Germany2
Received 16 April 2001/Accepted 12 July 2001
Interferon (IFN) type I (alpha/beta IFN [IFN-
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9596-9600.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Interleukin-12- and Gamma Interferon-Dependent Innate
Immunity Are Essential and Sufficient for Long-Term Survival of
Passively Immunized Mice Infected with Herpes Simplex Virus Type
1
/
]) is very
important in directly controlling herpes simplex virus type I (HSV-1) replication as well as in guiding and upregulating specific immunity against this virus. By contrast, the roles of IFN type II (IFN-
) and
antibodies in the defense against HSV-1 are not clear. Mice without a
functional IFN system and no mature B and T cells (AGR mice) did not
survive HSV-1 infection in the presence or absence of neutralizing
antibodies to the virus. Mice without a functional IFN type I system
and with no mature B and T cells (AR129 mice) were unable to control
infection with as little as 10 PFU of HSV-1 strain F. By contrast, in
the presence of passively administered neutralizing murine antibodies
to HSV-1, some AR129 mice survived infection with up to104
PFU of HSV-1. This acute immune response was dependent on the presence
of interleukin-12 (IL-12) p75. Interestingly, some virus-infected mice
stayed healthy for several months, at which time antibody to HSV-1 was
no longer detectable. Treatment of these virus-exposed mice with
dexamethasone led to death in approximately 40% of the mice. HSV-1 was
found in brains of mice that did not survive dexamethasone treatment,
whereas HSV-1 was absent in those that survived the treatment. We
conclude that in the presence of passively administered HSV-1-specific
antibodies, the IL-12-induced IFN-
-dependent innate immune response
is able to control low doses of virus infection. Surprisingly, in a
significant proportion of these mice, HSV-1 appears to persist in the
absence of antibodies and specific immunity.
*
Corresponding author. Mailing address: Institute of
Virology, University of Zurich, Winterthurerstr. 266a, CH-8057 Zurich, Switzerland. Phone: 41 1 635 87 17. Fax: 41 1 635 89 11. E-mail: msuter{at}vetvir.unizh.ch.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|